REN and COVID-19: Systematic reviews and meta-analyses as well as Mendelian randomisation analyses among the general population also indicated a lower risk of severe COVID-19 with chronic use of statins and renin inhibitors, supporting our findings from meta-analyses adjusted for important confounders [195–198].